ECP 2024 Final Programme

224 Sunday, 8 Sept Industry Symposia e Saturday, 7 September 2024 LS-01 Industry Symposium 16:45–18:15 Spadolini 3 Advancing precision medicine in oncol- ogy diagnostics: the role of quality HRD testing, ctDNA, and biomarkers in detection and treatment AstraZeneca Chair: Nicola Fusco, Italy 001 16:45–17:15 Sequencing biomarker testing, guideline updates and AI integration in BC pathology Nicola Fusco, Italy 002 17:15–17:45 Upholding standards: the critical role of quality and consistency in HRD testing Simon Patton, United Kingdom 003 17:45–18:15 Navigating the maze: challenges and solutions in ctDNA testing Gerhardt Attard, United Kingdom e Sunday, 8 September 2024 BRS-01 Industry Symposium 07:15–08:15 Spadolini 6 Revolutionizing pathology through immersive innovation Paige 001 Revolutionizing pathology through immersive innovation Juan Retamero, Spain and members of Paige LS-02 Industry Symposium 13:00–14:30 Spadolini 2 All you need to HER2 know Daiichi-Sankyo Chair: Giuseppe Viale, Italy 001 13:00–13:05 Welcome and introduction Giuseppe Viale, Italy 002 13:05–13:25 Treating cancer in the evolving era of HER2 Grazia Arpino, Italy 003 13:25–13:45 Identifying the whole spectrum of HER2: lessons learned Roberto Salgado, Belgium 004 13:45–14:05 Beyond breast: similarities in identifying HER2 in gastric cancer and differences in lung cancer Josef Rüschoff, Germany 005 14:05–14:25 Panel discussion and Q&A Giuseppe Viale, Italy 006 14:25–14:30 Wrap-up and meeting close Giuseppe Viale, Italy Saturday, 7 Sept